Skip to main content
Gabriel Ghiaur, MD, Oncology, Baltimore, MD

GabrielGhiaurMD

Oncology Baltimore, MD

Hematologic Oncology

Assistant Professor of Oncology, Johns Hopkins University School of Medicine; Assistant Professor of Medicine and Oncology

Dr. Ghiaur is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Ghiaur's full profile

Already have an account?

  • Office

    600 N Wolfe St
    Baltimore, MD 21287
    Phone+1 410-955-4199
    Fax+1 410-367-2194

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2009 - 2012
  • Christ Hospital
    Christ HospitalResidency, Internal Medicine, 2006 - 2009
  • Carol Davila University of Medicine and Pharmacy
    Carol Davila University of Medicine and PharmacyClass of 2001

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2009 - 2026
  • OH State Medical License
    OH State Medical License 2006 - 2011

Publications & Presentations

PubMed

Abstracts/Posters

  • CD38 Knockout Primary NK Cells to Prevent Fratricide and Boost Daratumumab Activity
    Gabriel Ghiaur, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Coagulopathy, Hypoxemia, and Mortality Outcomes in Newly Diagnosed Acute Myeloid Leukemia with Hyperleukocytosis Treated with Large Volume Leukapheresis
    Gabriel Ghiaur, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Laboratory & Translational Hematology 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Microenvironment Induced Myelophthisis Caused By CYP26 Deficiency 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Characteristics and Outcome of Older Patients with Acute Promyelocytic Leukemia Front-Line Treated with or without Arsenic Trioxide - an International Collaborative Study 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Kiadis Announces Publication in Blood Highlighting Proof-of-Concept to Enhance Potency of Anti-CD38 Antibodies with Kiadis’ K-nK004, Recently Licensed by Sanofi
    Kiadis Announces Publication in Blood Highlighting Proof-of-Concept to Enhance Potency of Anti-CD38 Antibodies with Kiadis’ K-nK004, Recently Licensed by SanofiJuly 22nd, 2020
  • Slingshot Insights Hosts Informative Call on Moleculin Biotech: Here Are the Details
    Slingshot Insights Hosts Informative Call on Moleculin Biotech: Here Are the DetailsJune 22nd, 2016

Other Languages

  • Romanian